According to a news report by Reuters, the Senate Health, Education, Labor and Pensions Committee has voted to advance the nomination of Dr Scott Gottlieb as director of the US Food and Drug Administration.
The [Committee] voted 14-9 in favor of Gottlieb, a physician, conservative health policy expert and a deputy FDA commissioner during the George W. Bush administration, Reuters reports.
According to Medscape, Gottlieb is a board director or adviser to a number of drug and medical device manufacturers such as GlaxoSmithKline and Tolero Pharmaceuticals. He also is a managing director of an investment banking firm that specializes in healthcare, and a venture partner in a venture capital firm that has invested in healthcare companies.
Gottlieb’s nomination will now be voted on by the full Senate. He is expected to be confirmed, according to Reuters and other media outlets.
